Literature DB >> 12966085

Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways.

Paul Dowell1, Tamara C Otto, Saleh Adi, M Daniel Lane.   

Abstract

The forkhead factor Foxo1 (or FKHR) was identified in a yeast two-hybrid screen as a peroxisome proliferator-activated receptor (PPAR) gamma-interacting protein. Foxo1 antagonized PPARgamma activity and vice versa indicating that these transcription factors functionally interact in a reciprocal antagonistic manner. One mechanism by which Foxo1 antagonizes PPARgamma activity is through disruption of DNA binding as Foxo1 inhibited the DNA binding activity of a PPARgamma/retinoid X receptor alpha heterodimeric complex. The Caenorhabditis elegans nuclear hormone receptor, DAF-12, interacted with the C. elegans forkhead factor, DAF-16, paralleling the interaction between PPARgamma and Foxo1. daf-12 and daf-16 have been implicated in C. elegans insulin-like signaling pathways, and PPARgamma and Foxo1 likewise have been linked to mammalian insulin signaling pathways. These results suggest a convergence of PPARgamma and Foxo1 signaling that may play a role in insulin action and the insulinomimetic properties of PPARgamma ligands. A more general convergence of nuclear hormone receptor and forkhead factor pathways may be important for multiple biological processes and this convergence may be evolutionarily conserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966085     DOI: 10.1074/jbc.M309069200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  94 in total

Review 1.  The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.

Authors:  Lars P Van Der Heide; Marco F M Hoekman; Marten P Smidt
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

2.  Putting the brakes on FOXO1 in fat.

Authors:  Jane J Kim; Wuqiang Fan; Jerrold M Olefsky
Journal:  EMBO J       Date:  2012-04-17       Impact factor: 11.598

Review 3.  New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder.

Authors:  Min Cui; Yunlong Huang; Yong Zhao; Jialin Zheng
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

4.  FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages.

Authors:  Wuqiang Fan; Hidetaka Morinaga; Jane J Kim; Eunju Bae; Nathanael J Spann; Sven Heinz; Christopher K Glass; Jerrold M Olefsky
Journal:  EMBO J       Date:  2010-11-02       Impact factor: 11.598

5.  Nuclear FoxO1 inflames insulin resistance.

Authors:  John E Dominy; Pere Puigserver
Journal:  EMBO J       Date:  2010-12-15       Impact factor: 11.598

6.  The nuclear orphan receptor Nur77 is a lipotoxicity sensor regulating glucose-induced insulin secretion in pancreatic β-cells.

Authors:  Olivier Briand; Audrey Helleboid-Chapman; Maheul Ploton; Nathalie Hennuyer; Rodolphe Carpentier; François Pattou; Brigitte Vandewalle; Ericka Moerman; Valery Gmyr; Julie Kerr-Conte; Jérôme Eeckhoute; Bart Staels; Philippe Lefebvre
Journal:  Mol Endocrinol       Date:  2012-02-02

7.  FoxO1 and hepatic lipid metabolism.

Authors:  Janet D Sparks; Henry H Dong
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

Review 8.  Metabolic reprogramming in dietary restriction.

Authors:  Rozalyn M Anderson; Richard Weindruch
Journal:  Interdiscip Top Gerontol       Date:  2007

9.  Identification of C. elegans DAF-12-binding sites, response elements, and target genes.

Authors:  Yuriy Shostak; Marc R Van Gilst; Adam Antebi; Keith R Yamamoto
Journal:  Genes Dev       Date:  2004-10-15       Impact factor: 11.361

10.  Serum- and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via forkhead box O1.

Authors:  Natalia Di Pietro; Valentine Panel; Schantel Hayes; Alessia Bagattin; Sunitha Meruvu; Assunta Pandolfi; Lynne Hugendubler; Geza Fejes-Tóth; Aniko Naray-Fejes-Tóth; Elisabetta Mueller
Journal:  Mol Endocrinol       Date:  2009-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.